While the triple treatment with RT, DTIC and HT in the absence of zVAD-fmk already induced a significant increased infiltration of CD8+ T cells into the tumor, zVAD-fmk in combination with RT further enhanced this (Figure 6a1). The gene discussed is CD8A; the disease is neoplasm.